Literature DB >> 32345929

Lateral Extra-articular Tenodesis in Anterior Cruciate Ligament Reconstruction.

Alan Getgood1, Gilbert Moatshe.   

Abstract

A subset of patients have residual rotational laxity following anterior cruciate ligament reconstruction (ACLR) despite the evolution of ACLR techniques. In recent years, there has been increased interest in addressing residual laxity because it is associated with poor outcomes after ACLR. There is an expanding body of knowledge on the anatomy and biomechanics of the anterolateral soft tissue restraints in regard to their rotational control of the knee and this has reignited an interest in extra-articular reconstruction techniques for augmenting ACLR. Reconstruction techniques currently used can be broadly categorized as either lateral extra-articular tenodesis or anterolateral ligament reconstruction. In this review, we discuss the relevant anatomy, biomechanics, and rationale behind the indications and technique of our current extra-articular augmentation procedure.

Entities:  

Mesh:

Year:  2020        PMID: 32345929     DOI: 10.1097/JSA.0000000000000278

Source DB:  PubMed          Journal:  Sports Med Arthrosc Rev        ISSN: 1062-8592            Impact factor:   1.985


  3 in total

1.  Role of network cloud platform-based and progressive health education in postoperative rehabilitation of patients with tibial fracture.

Authors:  Ding Wang; Xiang Lv; Shaofeng Zhang; Taiping Zhu
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

2.  Combined lateral extra-articular tenodesis and anterior cruciate ligament reconstruction: risk of osteoarthritis.

Authors:  Jonas Declercq; Margot Schuurmans; Lore Tack; Cato Verhelst; Jan Truijen
Journal:  Eur J Orthop Surg Traumatol       Date:  2022-04-01

3.  Slope-Correction Osteotomy with Lateral Extra-articular Tenodesis and Revision Anterior Cruciate Ligament Reconstruction Is Highly Effective in Treating High-Grade Anterior Knee Laxity.

Authors:  Ralph Akoto; Lena Alm; Tobias Claus Drenck; Jannik Frings; Matthias Krause; Karl-Heinz Frosch
Journal:  Am J Sports Med       Date:  2020-11-02       Impact factor: 6.202

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.